All News
RheumNowLive On Demand: The History of Fibromyalgia - Dr. Fred Wolfe
d
RheumNow
A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.
Read Article
RheumNowLive On Demand: Development & Use of JAK Inhibitors - Dr. John O'Shea
d
RheumNow
A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.
Read Article
RheumNowLive On Demand: The History of Steroids - Dr. Eric Matteson
d
RheumNow
A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.
Read Article
RheumNowLive On Demand: MTX Impact in RA - Dr. Michael Weinblatt
d
RheumNow
A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.
Read Article
RheumNowLive On Demand: Pre-Clinical RA - Dr. Michael Holers
d
RheumNow
A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.
Read Article
RheumNowLive On Demand: Infection Prevention and Management with Newer Agents - Jack Cush, MD
d
RheumNow
A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.
Read Article
RheumNow Podcast – Loretta Lynn Arthritis (3.29.19)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.
Read Article
Important point! - Many patients with SpA may have FMS - BUT - FMS patients don't meet SpA criteria. - Dr Eric Ruderman @JointMD #rnl2019 https://t.co/aDIpgX8Ihj
caocosm caocosm ( View Tweet)
#RNL2019 Dr Carol Langford discusses when to use RTX vs CTX in GPA https://t.co/w0vWVrf7JX
Dr. John Cush RheumNow ( View Tweet)
In newly Dx GPA it’s ok to treat with steroids PLUS MTX or MMF or RTX. #RNL2019 Dr Carol Langford https://t.co/rihhR6x7u3
Dr. John Cush RheumNow ( View Tweet)
Distinguishing b/t AS and nonradiographic SpA (AS more likely to be males; higher CRP); nonradiographic SpA more likely female; more have FM symptoms; lower CRP Dr E Ruderman #rnl2019 https://t.co/wb7WuPAoUF
k dao KDAO2011 ( View Tweet)
Erdheim Chester dz as a mimic of vasculitis or IgG4 related disease. Pearls from #RNL2019 Dr. Philip Seo https://t.co/TPuLfwG5Ye
Dr. John Cush RheumNow ( View Tweet)
Ascending aortic involvement - you should do genetic testing to r/o Marfans >> or Ehlers Danilo’s. Here’s how. #RNL2019 - Dr. Philip Seo https://t.co/ISqWuSSdR3
Dr. John Cush RheumNow ( View Tweet)
Biologic Treatment of Giant Cell Arteritis. Paul Monach in #RNL2019 #vasculitis @RheumNow https://t.co/2iahcf1Vwp
MedR #QuedateEnCasa MedReuma ( View Tweet)
Following along with #RNL2019 for free! Very slick format. Dr. Conaghan echoing my recent thoughts on U/S from Episode 32 on TaSER and ARCTIC trials: don't use for TtT, but important role when diagnosis uncertain and has prognostic value. @UltrasoundRheum @uptoTate @RheumNow https://t.co/mnweGvGkaw
Mike Putman EBRheum ( View Tweet)
Dr Phil Conaghan on the similarity between OA and PsA #RNL2019 https://t.co/za9YDAWilE
Dr. John Cush RheumNow ( View Tweet)
Took away so much from #RNL2019, but most importantly took a photo with the Godfather of rheumatology @RheumNow! #celebritiesinrheumatology https://t.co/EvXrUXJUGc
Dima Nimri Dima_Nimri ( View Tweet)
The genetics of ANKYLOSING SPONDYLITIS. #RNL2019 - Dr. John Reveille https://t.co/wIszzNqU01
Dr. John Cush RheumNow ( View Tweet)
Dr Carol Langford lecturing at S Carolina Rheum Assn. 1) EGPA usually ANCA negative. 2) a +ANCA does not = a Dx of Vasculitis. 3) +ANCA has a predictive value=90% if renal dz present; but PPV down to 30-60% if only sinus & pulmonary dz present. https://t.co/RfIQEUliRb
Dr. John Cush RheumNow ( View Tweet)
340 CCP+ persons without followed for 1047 PYrs = 21.5% developed RA. Risk of RA progression increased w/ CCP level. 46.0% of high level CCP patients progressedto RA by 5 years. High vs low CCP were 5 times more likely to get RA (HR 4.83, 95%CI 2.51-9.31). https://t.co/V3cRnMzerw
Links:
Dr. John Cush RheumNow ( View Tweet)